Promising But Overstated

The discovery remains scientifically interesting, but later analysis shows it is less comparable to CRISPR than Anthropic's initial framing suggested. Investors and researchers still see value in autonomous AI labs, but near-term commercial expectations are tempered.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.